GSK plc GSK reported fourth-quarter 2024 core earnings of 59 cents per American depositary share (ADS), which beat the Zacks ...

That hasn’t stopped Bexsero’s steady growth, with sales approaching the $1 billion threshold last year, while Menveo added another $430 million. Pfizer has been something of an also-ran in the ...

with the falls offset partially by gains for its meningitis jabs Bexsero and Menveo, which rose 22% to £520 million. Overall, vaccine sales were down 15%, and GSK cut its forecast for the ...

8,47,03,017 Bonus shares have been issued by capitalization of profits transferred from general reserve.In December 2019, the Company launched Menveo a Quadrivalent Meningococcal Conjugate Vaccine ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.